Related Experiment Video
Updated: Mar 15, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Design and performance of a large lumen glaucoma drainage device
1Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, Aurora, CO, USA.
This study tested a new large-lumen glaucoma drainage device (LL-GDD) with a laser-adjustable flow regulator. The device successfully lowered intraocular pressure (IOP) on demand, preventing hypotony and allowing precise IOP control in rabbits.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Medical Devices
Background:
- Glaucoma drainage devices (GDDs) are crucial for managing intraocular pressure (IOP).
- Current GDDs may face challenges with immediate postoperative hypotony or require invasive adjustments.
- A GDD with adjustable aqueous humor outflow could offer improved IOP control.
Purpose of the Study:
- To evaluate the in vivo performance of a novel large-lumen glaucoma drainage device (LL-GDD).
- To assess the efficacy of a laser-adjustable flow regulator integrated into the LL-GDD for IOP management.
- To determine the device's ability to prevent postoperative hypotony and allow IOP reduction on demand.
Main Methods:
- Prototypes of the LL-GDD were constructed using silicone angiocatheters and a PVDF membrane.
- The device was tested in a model eye and subsequently in New Zealand white rabbits, with fellow eyes serving as controls.
- Intraocular pressure (IOP) was monitored, and laser procedures were performed postoperatively to adjust the membrane and aqueous flow.
Main Results:
- The LL-GDD implantation resulted in a significant average IOP reduction of 5.5 mm Hg (P=0.001).
- A first laser procedure at week 5 led to an additional average IOP decrease of 1.8 mm Hg.
- A second laser procedure to fully open the membrane caused a further average IOP drop of 2.7 mm Hg, maintained until study termination.
Conclusions:
- The large-lumen glaucoma drainage device (LL-GDD) effectively lowered IOP in a rabbit model.
- The integrated laser-adjustable membrane allowed for non-invasive, on-demand IOP reduction.
- This proof-of-concept study demonstrates the LL-GDD's potential to prevent hypotony and provide adjustable IOP control in glaucoma management.
More Related Videos
07:30Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...